772 related articles for article (PubMed ID: 18199832)
1. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
Dupuis L; Corcia P; Fergani A; Gonzalez De Aguilar JL; Bonnefont-Rousselot D; Bittar R; Seilhean D; Hauw JJ; Lacomblez L; Loeffler JP; Meininger V
Neurology; 2008 Mar; 70(13):1004-9. PubMed ID: 18199832
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia in ALS: good, bad, or unclear?
Albert SM
Neurology; 2008 Mar; 70(13):988-9. PubMed ID: 18362279
[No Abstract] [Full Text] [Related]
3. Lower serum lipid levels are related to respiratory impairment in patients with ALS.
Chiò A; Calvo A; Ilardi A; Cavallo E; Moglia C; Mutani R; Palmo A; Galletti R; Marinou K; Papetti L; Mora G
Neurology; 2009 Nov; 73(20):1681-5. PubMed ID: 19917991
[TBL] [Abstract][Full Text] [Related]
4. Natural history of young-adult amyotrophic lateral sclerosis.
Sabatelli M; Madia F; Conte A; Luigetti M; Zollino M; Mancuso I; Lo Monaco M; Lippi G; Tonali P
Neurology; 2008 Sep; 71(12):876-81. PubMed ID: 18596241
[TBL] [Abstract][Full Text] [Related]
5. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
6. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
[TBL] [Abstract][Full Text] [Related]
7. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis.
Zoccolella S; Simone IL; Lamberti P; Samarelli V; Tortelli R; Serlenga L; Logroscino G
Neurology; 2008 Jan; 70(3):222-5. PubMed ID: 18195267
[TBL] [Abstract][Full Text] [Related]
9. [Survival in amyotrophic lateral sclerosis].
Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
[TBL] [Abstract][Full Text] [Related]
10. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?
Vaisman N; Lusaus M; Nefussy B; Niv E; Comaneshter D; Hallack R; Drory VE
J Neurol Sci; 2009 Apr; 279(1-2):26-9. PubMed ID: 19185883
[TBL] [Abstract][Full Text] [Related]
11. Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial.
Rafiq MK; Lee E; Bradburn M; McDermott CJ; Shaw PJ
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):478-84. PubMed ID: 26161993
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.
Ghandehari H; Kamal-Bahl S; Wong ND
Am Heart J; 2008 Jul; 156(1):112-9. PubMed ID: 18585505
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
[TBL] [Abstract][Full Text] [Related]
14. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
Desport JC; Marin B; Funalot B; Preux PM; Couratier P
Amyotroph Lateral Scler; 2008 Oct; 9(5):273-8. PubMed ID: 18720089
[TBL] [Abstract][Full Text] [Related]
15. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
16. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
[TBL] [Abstract][Full Text] [Related]
17. Do bulbar-onset amyotrophic lateral sclerosis patients have an earlier respiratory involvement than spinal-onset amyotrophic lateral sclerosis patients?
Pinto S; Pinto A; De Carvalho M
Eura Medicophys; 2007 Dec; 43(4):505-9. PubMed ID: 18084174
[TBL] [Abstract][Full Text] [Related]
18. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Iwata M; Morikawa S; Hirano A; Kobayashi M
Neurodegener Dis; 2009; 6(3):118-26. PubMed ID: 19372705
[TBL] [Abstract][Full Text] [Related]
19. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
20. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
